Pharmaceuticals South Africa

South Africa Bacteriophage Therapy Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

South Africa Bacteriophage Therapy Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

South Africa · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.5 Mn Placeholder estimate
Estimate 2025 $0.5 Mn 0.7% of the global market
Projected 2034 $2.1 Mn 295.3% Adds $1.6 Mn over 9 forecast years
CAGR 2025–2034 16.5% Faster than 77% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • South Africa is 0.68% of the global market.
  • In Africa, the largest is South Africa (this report) at $0.5 Mn.
  • Fastest growing: South Africa (this report) at 16.5% a year.
  • South Africa ranks 1st of 3 by size in Africa.

Market size projection

South Africa

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Bacteriophage Therapy Market market size by year, South Africa
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.5 Mn — —
2025 (base) $0.5 Mn +$0.1 Mn —
2026 (forecast) $0.6 Mn +$0.1 Mn +16.5%
2027 (forecast) $0.7 Mn +$0.1 Mn +35.7%
2028 (forecast) $0.9 Mn +$0.1 Mn +58.1%
2029 (forecast) $1.0 Mn +$0.1 Mn +84.2%
2030 (forecast) $1.2 Mn +$0.2 Mn +114.6%
2031 (forecast) $1.4 Mn +$0.2 Mn +150%
2032 (forecast) $1.6 Mn +$0.2 Mn +191.3%
2033 (forecast) $1.8 Mn +$0.3 Mn +239.3%
2034 (forecast) $2.1 Mn +$0.3 Mn +295.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

South Africa Bacteriophage Therapy Market Analysis at a glance
Market size, 2025$0.5 Mn placeholder estimate
Forecast, 2034$2.1 Mn placeholder estimate
Growth (CAGR), 2025–203416.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersArmata Pharmaceuticals, Locus Biosciences, Adaptive Phage Therapeutics, BiomX, Intralytix (see all)
Regulator in South AfricaSAHPRASource: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The South Africa Bacteriophage Therapy Market Analysis Executive Summary

Bacteriophage therapy uses viruses that infect only bacteria to treat infections that antibiotics cannot clear.

Key segments of the bacteriophage Therapy market include type (Natural Phages, Engineered Phages and Phage Cocktails) and application (Chronic Wounds, Respiratory Infections and Urinary Infections).

Bar chart: South Africa Bacteriophage Therapy market size, 2024–2034, placeholder estimates. $0.5 Mn in 2024, $0.5 Mn in 2025 and $2.1 Mn in 2034, 16.5% CAGR.
South Africa Bacteriophage Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

South Africa Bacteriophage Therapy Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the bacteriophage Therapy market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the bacteriophage Therapy market.

Competitive Landscape for Bacteriophage Therapy Market in South Africa

The bacteriophage Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Bacteriophage Therapy Market in South Africa

Bacteriophage Therapy in South Africa: rules and payment

The South African Health Products Regulatory Authority (SAHPRA) registers medicines.⁠[1] Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone.⁠[2]

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for bacteriophage Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in South Africa.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Bacteriophage Therapy right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Bacteriophage Therapy in context

South Africa compared

  • Health spending per person: 537 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in Africa.[1]
  • Doctors: 0.79 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in Africa.[2]
  • People aged 65 and over: 6.9% of people (2025). World: 10.4% of people (2025). 2nd highest of the 17 countries we cover in Africa.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Bacteriophage Therapy market in South Africa?
Placeholder estimate: about $0.5 Mn in 2025, rising to about $2.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Bacteriophage Therapy market in South Africa growing?
Placeholder estimate: about 16.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Bacteriophage Therapy market report cover?
The report splits the market by type (Natural Phages, Engineered Phages, Phage Cocktails), application (Chronic Wounds, Respiratory Infections, Urinary Infections, Animal Health) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Bacteriophage Therapy market?
Key players include Armata Pharmaceuticals, Locus Biosciences, Adaptive Phage Therapeutics, BiomX and Intralytix.
What is driving the Bacteriophage Therapy market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.
Who regulates Bacteriophage Therapy in South Africa?
The South African Health Products Regulatory Authority (SAHPRA) registers medicines. Source: South African Health Products Regulatory Authority. Checked 14 Nov 2026.
How is healthcare paid for in South Africa?
Most people use public health services and a minority belong to private medical schemes; the National Health Insurance Act, signed in May 2024, plans to fund care for everyone. Source: National Department of Health. Checked 14 Nov 2026.
How much research is published on Bacteriophage Therapy?
PubMed lists 957 papers on Bacteriophage Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in South Africa

See all

Related on antibiotics and infectious diseases

See the topic